Orange Book product · Generic (ANDA)
LAPATINIB DITOSYLATE
LAPATINIB DITOSYLATE
Generic (ANDA)ANDA 203007TE ABRX NATCO PHARMA LTD
At a glance
Sep 29, 2020
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 29, 2020
5 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
LAPATINIB DITOSYLATE
Strength
EQ 250MG BASE
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 203007
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LAPATINIB DITOSYLATE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
